Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

Background Methods to improve stratification of small (≤15 mm) lung nodules are needed. We aimed to develop a radiomics model to assist lung cancer diagnosis. Methods Patients were retrospectively identified using health records from January 2007 to December 2018. The external test set was obtained...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2023-12, Vol.129 (12), p.1949-1955
Hauptverfasser: Hunter, Benjamin, Argyros, Christos, Inglese, Marianna, Linton-Reid, Kristofer, Pulzato, Ilaria, Nicholson, Andrew G., Kemp, Samuel V., L. Shah, Pallav, Molyneaux, Philip L., McNamara, Cillian, Burn, Toby, Guilhem, Emily, Mestas Nuñez, Marcos, Hine, Julia, Choraria, Anika, Ratnakumar, Prashanthi, Bloch, Susannah, Jordan, Simon, Padley, Simon, Ridge, Carole A., Robinson, Graham, Robbie, Hasti, Barnett, Joseph, Silva, Mario, Desai, Sujal, Lee, Richard W., Aboagye, Eric O., Devaraj, Anand
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Methods to improve stratification of small (≤15 mm) lung nodules are needed. We aimed to develop a radiomics model to assist lung cancer diagnosis. Methods Patients were retrospectively identified using health records from January 2007 to December 2018. The external test set was obtained from the national LIBRA study and a prospective Lung Cancer Screening programme. Radiomics features were extracted from multi-region CT segmentations using TexLab2.0. LASSO regression generated the 5-feature small nodule radiomics-predictive-vector (SN-RPV). K-means clustering was used to split patients into risk groups according to SN-RPV. Model performance was compared to 6 thoracic radiologists. SN-RPV and radiologist risk groups were combined to generate “Safety-Net” and “Early Diagnosis” decision-support tools. Results In total, 810 patients with 990 nodules were included. The AUC for malignancy prediction was 0.85 (95% CI: 0.82–0.87), 0.78 (95% CI: 0.70–0.85) and 0.78 (95% CI: 0.59–0.92) for the training, test and external test datasets, respectively. The test set accuracy was 73% (95% CI: 65–81%) and resulted in 66.67% improvements in potentially missed [8/12] or delayed [6/9] cancers, compared to the radiologist with performance closest to the mean of six readers. Conclusions SN-RPV may provide net-benefit in terms of earlier cancer diagnosis.
ISSN:0007-0920
1532-1827
1532-1827
DOI:10.1038/s41416-023-02480-y